Mount Sinai launches initiative to accelerate precision immunology treatments
Mount Sinai has launched the Precision Immunology and Experimental Medicine Trial Organization (PrIME Trials), a new initiative within the Marc and Jennifer Lipschultz Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai.
Read original article on The Medical News →